Skip to main content

Cardiovascular Risk Reduction Trial in Serious Mental Illness (IDEAL)

Members of the ALACRITY Center's IDEAL project study team standing together and holding a poster board with the IDEAL trial logo.

Persons with serious mental illness are at extremely high risk for morbidity and mortality from cardiovascular disease, and commonly have multiple modifiable cardiovascular disease risk factors. Funded by the National Heart, Lung, and Blood Institute, the IDEAL Trial tested a comprehensive cardiovascular risk reduction intervention in adults with serious mental illness in community outpatient mental health programs.

IDEAL was a randomized clinical trial in community mental health outpatient programs that found that an 18-month comprehensive cardiovascular risk reduction intervention incorporating behavioral counseling and care coordination/ care management significantly decreased overall cardiovascular disease risk for persons with serious mental illness. The individual-level intervention was delivered by a health coach and a nurse and addressed all cardiovascular risk behaviors and risk factors. Two hundred sixty-nine participants enrolled in the trial. We appreciate the partnership of Mosaic Community Services of the Sheppard Pratt Health System for this study. (R01HL112299)

The IDEAL trial was featured in a Cardiology Today article in June 2020.